Humana (HUM) has quietly climbed about 11% over the past month, outpacing its performance over the past 3 months and 3 years. That move has investors rechecking what they are really paying for its ...

Humana trades near fair value, reflecting a mixed profit outlook and Medicare Advantage uncertainties. Click here to read an ...

The bearish sentiment is evident in the stock's price action. Shares are currently trading at €284.40, a steep decline from their 52-week high of €532.50 and down more than 40% year-to-date. This ...

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 ...

Humana ( ($HUM) ) has shared an announcement. On December 16, 2025, Humana announced the retirement of George Renaudin, Insurance Segment ...

The fair value estimate for Humana has nudged higher to about $288 from roughly $287 as analysts factor in slightly stronger long term revenue growth assumptions around 9.5%, supported by improving ...

Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.

Four of the “magnificent 7” stocks have decided to invest a massive $380 billion in 2025 as capital expenditure for ...

In this week’s edition of InnovationRx, Medline’s blockbuster IPO, Fred Moll’s surgical robotics investments, Forbes' ...

Earlier this month, Humana cut its full-year earnings outlook, citing ongoing pressure in its Medicare Advantage business ...

CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read ...

In a notable shift for investors, Humana Inc. (NYSE: HUM) received a ‘Buy’ rating from Jefferies analyst David Windley o. The analyst suggests a price target of $313, representing a significant upside ...